Skip to content

JSPR

Jasper Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.48
−0.52%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
11.24x
Price / sales
—
Price / cash flow
-0.26x

Enterprise value

Enterprise value
$8.8M
EV / sales
—
EV / EBITDA
-0.28x
EV / EBIT
-0.16x
Market cap
$15.9M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026